83 FR 8288 - Advisory Commission on Childhood Vaccines
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 83, Issue 38 (February 26, 2018)
Health Resources and Services Administration
Federal Register Volume 83, Issue 38 (February 26, 2018)
| Page Range | 8288-8289 | |
| FR Document | 2018-03812 |
[Federal Register Volume 83, Number 38 (Monday, February 26, 2018)] [Notices] [Pages 8288-8289] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-03812] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Commission on Childhood Vaccines AGENCY: Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: In accordance with the Federal Advisory Committee Act, notice is hereby given that a meeting is scheduled for the Advisory Commission on Childhood Vaccines (ACCV). This meeting will be open to the public. Information about the ACCV and the agenda for this meeting can be obtained by accessing the following website: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html. DATES: The meeting will be held on March 8, 2018, at 10:00 a.m. ET. ADDRESSES: This meeting will be held via Adobe Connect meeting and conference call. This is not an in-person meeting. The public can join the meeting by: 1. (Audio Portion) Calling the conference phone number (800) 988- 0218 and providing the following information: Leader Name: Dr. Narayan Nair. Password: 9302948. 2. (Visual Portion) Connecting to the ACCV Adobe Connect Meeting using the following URL: https://hrsa.connectsolutions.com/accv/. Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview. [[Page 8289]] FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, Division of Injury Compensation Programs (DICP), HRSA in one of three ways: (1) Send a request to the following address: Annie Herzog, Program Analyst, DICP, HRSA, 5600 Fishers Lane, 08N146B, Rockville, Maryland 20857; (2) call (301) 443-6593; or (3) send an email to [email protected]. The ACCV will meet on Thursday, March 8, 2018, beginning at 10:00 a.m. via Adobe Connect Meeting; however, meeting times and information to join the meeting and/or conference call could change. For the latest information regarding meeting start time and information to join the meeting and/or conference call, please check the ACCV website: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html. SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as enacted by Public Law (Pub. L.) 99-660, and as subsequently amended, and advises the Secretary of HHS (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). Other activities of the ACCV include: Recommending changes to the Vaccine Injury Table at its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 of the Act regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying federal, state, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b) of the Act; advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; consulting on the development or revision of Vaccine Information Statements; and, recommending to the Director of the National Vaccine Program research related to vaccine injuries which should be conducted to carry out the VICP. The agenda items for the March 8, 2018, meeting will include, but are not limited to, updates from DICP, Department of Justice (DOJ), National Vaccine Program Office (NVPO), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV website: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html prior to the meeting. Agenda items are subject to change as priorities dictate. Members of the public will have the opportunity to provide comments. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or provide written comments to the ACCV should be sent to Annie Herzog by March 5, 2018, using the address and phone number above. Individuals who plan to participate and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Annie Herzog, using the address and phone number above at least 10 days prior to the meeting. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018-03812 Filed 2-23-18; 8:45 am] BILLING CODE 4165-15-P
![8288 Federal Register / Vol. 83, No. 38 / Monday, February 26, 2018 / Notices
members, including two co-chairs. The education, patient healthcare delivery, research grants or contracts. Disclosure
Committee membership maintains a and prevention services; Agency of this information is necessary in order
balance of diverse experiences and policies about prevention of HIV, viral to determine if the selected candidate is
expertise. Those requesting hepatitis and other STDs, treatment, involved in any activity that may pose
consideration require expertise in areas healthcare delivery, and research and a potential conflict with the official
such as: Public health; epidemiology; training; strategic issues influencing the duties to be performed as a member of
laboratory practice; immunology; ability of CDC and HRSA to fulfill their the Committee.
infectious diseases; behavioral health missions of providing prevention and
Amy McNulty,
and science including, but not limited treatment services; programmatic efforts
to opioid use and related expertise; to prevent and treat HIV, viral hepatitis, Acting Director, HRSA, Division of the
and other STDs; and support to the Executive Secretariat.
health education; healthcare delivery;
Agencies in their developoment of [FR Doc. 2018–03853 Filed 2–23–18; 8:45 am]
state health programs; clinical care;
preventive health; medical education; responses to emerging health needs BILLING CODE 4165–15–P
health services and clinical research; related to HIV, viral hepatitis, and other
and healthcare financing. In addition, STDs.
Members selected will be considered DEPARTMENT OF HEALTH AND
people living with HIV and affected
special government employees (SGEs) HUMAN SERVICES
populations as well as individuals
employed by state and local health and and may be invited to serve four (4) year
terms. SGEs are eligible to receive a Health Resources and Service
education agencies, HIV/viral hepatitis/ Administration
STD community-based organizations, stipend and reimbursement for per diem
and the ethics or religious community and any travel expenses incurred for Advisory Commission on Childhood
are encouraged to submit nomination attending Committee meetings, as Vaccines
packages for consideration. Current authorized by section 5 U.S.C. 5703 for
federal employees will not be persons employed intermittently in AGENCY: Health Resources and Service
considered. government service. Approved Administration (HRSA), Department of
nominees will be invited to serve during Health and Human Services (HHS).
DATES: Written nominations for calendar year 2019. ACTION: Notice of meeting.
membership to the Committee must be The following information must be
received on or before May 30, 2018. included in the electronic nomination SUMMARY: In accordance with the
Packages received after this time will package for each individual to be Federal Advisory Committee Act, notice
not be considered for the current considered for nomination: (1) A is hereby given that a meeting is
membership cycle. (See SUPPLEMENTARY statement clearly indicating the name scheduled for the Advisory Commission
INFORMATION, below, for required and affiliation of the nominee, the basis on Childhood Vaccines (ACCV). This
documentation.) for the nomination (i.e., specific meeting will be open to the public.
ADDRESSES: Submit your electronic attributes such as experience, education, Information about the ACCV and the
nomination package by electronic mail current affiliations, positions, etc.), and agenda for this meeting can be obtained
to CHACAdvisoryComm@hrsa.gov. that the nominee is willing to serve as by accessing the following website:
FOR FURTHER INFORMATION CONTACT: CDR
a member of the Committee; (2) the http://www.hrsa.gov/
Holly Berilla, HRSA, HIV/AIDS Bureau nominee’s name, address, and daytime advisorycommittees/childhoodvaccines/
by email at CHACAdvisoryComm@ telephone number and the home/or index.html.
hrsa.gov or by telephone at (301) 443– work address, and email address; and
(3) a current copy of the nominee’s DATES: The meeting will be held on
9965. A copy of the Committee Charter March 8, 2018, at 10:00 a.m. ET.
and background information can be curriculum vitae. Nomination packages
may be summited directly by the ADDRESSES: This meeting will be held
obtained by accessing the Advisory via Adobe Connect meeting and
individual being nominated or by the
Committee website at https:// conference call. This is not an in-person
person/organization recommending the
www.cdc.gov/maso/facm/ meeting. The public can join the
candidate.
facmchachspt.html. HHS is required to ensure that the meeting by:
SUPPLEMENTARY INFORMATION: The CDC/ membership of the Committee is 1. (Audio Portion) Calling the
HRSA Advisory Committee on HIV, balanced in terms of points of view conference phone number (800) 988–
Viral Hepatitis and STD Prevention and represented. Every effort is made to 0218 and providing the following
Treatment was established under ensure that individuals from a broad information:
Section 222 of the Public Health Service representation of geographic areas, Leader Name: Dr. Narayan Nair.
(PHS) Act, [42 U.S.C. Section 217a], as gender, ethnic and minority groups, as Password: 9302948.
amended. well as individuals with disabilities are 2. (Visual Portion) Connecting to the
The purpose of the Committee is to given consideration for membership and ACCV Adobe Connect Meeting using the
advise the Secretary, HHS; the Director, therefore, HHS encourages nominations following URL: https://
CDC; and the Administrator, HRSA of qualified candidates from these hrsa.connectsolutions.com/accv/.
regarding objectives, strategies, policies, groups. HHS also encourages geographic Participants should call and connect 15
and priorities for HIV, viral hepatitis, diversity in the composition of the minutes prior to the meeting in order for
and other STD prevention and treatment Committee. Appointments shall be logistics to be set up. If you have never
efforts including surveillance of HIV made without discrimination based on attended an Adobe Connect meeting,
daltland on DSKBBV9HB2PROD with NOTICES
infection, AIDS, viral hepatitis, and age, ethnicity, gender, sexual please test your connection using the
other STDs, and related behaviors; orientation, and cultural, religious, or following URL: https://
epidemiologic, behavioral, health socioeconomic status. hrsa.connectsolutions.com/common/
services, and laboratory research on Individuals who are selected for help/en/support/meeting_test.htm and
HIV, viral hepatitis, and other STDs; appointment will be required to provide get a quick overview by following URL:
identification of policy issues related to detailed information regarding their http://www.adobe.com/go/connectpro_
HIV/viral hepatitis/STD professional financial holdings, consultancies, and overview.
VerDate Sep<11>2014 17:58 Feb 23, 2018 Jkt 244001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\26FEN1.SGM 26FEN1](https://thefederalregister.org/doc/83_FR_8326/page/1.svg)
![Federal Register / Vol. 83, No. 38 / Monday, February 26, 2018 / Notices 8289
FOR FURTHER INFORMATION CONTACT: Disease Control and Prevention), Place: National Institutes of Health,
Anyone requesting information National Institute of Allergy and National Institute on Alcohol Abuse and
regarding the ACCV should contact Infectious Diseases (National Institutes Alcoholism, 5635 Fishers Lane Bethesda, MD
20892 (Telephone Conference Call).
Annie Herzog, Program Analyst, of Health) and Center for Biologics,
Contact Person: Ranga Srinivas, Ph.D.,
Division of Injury Compensation Evaluation and Research (Food and Chief, Extramural Project Review Branch,
Programs (DICP), HRSA in one of three Drug Administration). A draft agenda National Institute on Alcohol Abuse and
ways: (1) Send a request to the following and additional meeting materials will be Alcoholism, National Institutes of Health,
address: Annie Herzog, Program posted on the ACCV website: http:// 5365 Fishers Lane, Room 2085, Rockville,
Analyst, DICP, HRSA, 5600 Fishers www.hrsa.gov/advisorycommittees/ MD 20852, (301) 451–2067, srinivar@
Lane, 08N146B, Rockville, Maryland childhoodvaccines/index.html prior to mail.nih.gov.
20857; (2) call (301) 443–6593; or (3) the meeting. Agenda items are subject to Name of Committee: National Institute on
send an email to aherzog@hrsa.gov. change as priorities dictate. Alcohol Abuse and Alcoholism Special
The ACCV will meet on Thursday, Members of the public will have the Emphasis Panel; NIAAA Member Conflict
March 8, 2018, beginning at 10:00 a.m. opportunity to provide comments. Oral Applications—AA3.
Date: April 2, 2018.
via Adobe Connect Meeting; however, comments will be honored in the order
Time: 11:00 a.m. to 2:00 p.m.
meeting times and information to join they are requested and may be limited Agenda: To review and evaluate grant
the meeting and/or conference call as time allows. Requests to make oral applications.
could change. For the latest information comments or provide written comments Place: National Institutes of Health,
regarding meeting start time and to the ACCV should be sent to Annie National Institute on Alcohol Abuse and
information to join the meeting and/or Herzog by March 5, 2018, using the Alcoholism, 5635 Fishers Lane, Bethesda,
conference call, please check the ACCV address and phone number above. MD 20892 (Telephone Conference Call).
website: http://www.hrsa.gov/ Individuals who plan to participate and Contact Person: Ranga Srinivas, Ph.D.,
advisorycommittees/childhoodvaccines/ need special assistance, such as sign Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
index.html. language interpretation or other
Alcoholism, National Institutes of Health,
SUPPLEMENTARY INFORMATION: The ACCV reasonable accommodations, should 5365 Fishers Lane, Room 2085, Rockville,
was established by section 2119 of the notify Annie Herzog, using the address MD 20852, (301) 451–2067, srinivar@
Public Health Service Act (the Act) (42 and phone number above at least 10 mail.nih.gov.
U.S.C. 300aa–19), as enacted by Public days prior to the meeting. Name of Committee: National Institute on
Law (Pub. L.) 99–660, and as Amy McNulty, Alcohol Abuse and Alcoholism Initial
subsequently amended, and advises the Review Group; Epidemiology, Prevention
Acting Director, Division of the Executive and Behavior Research Review
Secretary of HHS (the Secretary) on Secretariat. Subcommittee.
issues related to implementation of the [FR Doc. 2018–03812 Filed 2–23–18; 8:45 am] Date: June 4, 2018.
National Vaccine Injury Compensation BILLING CODE 4165–15–P Time: 8:30 a.m. to 5:00 p.m.
Program (VICP). Agenda: To review and evaluate grant
Other activities of the ACCV include: applications.
Recommending changes to the Vaccine DEPARTMENT OF HEALTH AND Place: National Institutes of Health,
Injury Table at its own initiative or as HUMAN SERVICES National Institute on Alcohol Abuse and
the result of the filing of a petition; Alcoholism, 5635 Fishers Lane, Terrace Level
advising the Secretary in implementing National Institutes of Health Conference Room 508, Bethesda, MD 20892.
section 2127 of the Act regarding the Contact Person: Anna Ghambaryan, M.D.,
National Institute on Alcohol Abuse Ph.D., Scientific Review Officer, Extramural
need for childhood vaccination Project Review Branch, National Institute on
products that result in fewer or no and Alcoholism; Notice of Closed
Alcohol Abuse and Alcoholism, National
significant adverse reactions; surveying Meetings Institutes of Health, 5365 Fishers Lane, Room
federal, state, and local programs and Pursuant to section 10(d) of the 2019, Rockville, MD 20852, (301) 443–4032,
activities related to gathering Federal Advisory Committee Act, as anna.ghambaryan@nih.gov.
information on injuries associated with amended, notice is hereby given of the Name of Committee: National Institute on
the administration of childhood following meetings. Alcohol Abuse and Alcoholism Initial
vaccines, including the adverse reaction The meetings will be closed to the Review Group; Clinical, Treatment and
reporting requirements of section Health Services Research Review
public in accordance with the Subcommittee.
2125(b) of the Act; advising the provisions set forth in sections
Secretary on the methods of obtaining, Date: June 15, 2018.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Time: 8:00 a.m. to 5:30 p.m.
compiling, publishing, and using as amended. The grant applications and Agenda: To review and evaluate grant
credible data related to the frequency the discussions could disclose applications.
and severity of adverse reactions confidential trade secrets or commercial Place: Holiday Inn San Diego Bayside,
associated with childhood vaccines; property such as patentable material, 4875 North Harbor Drive, San Diego, CA
consulting on the development or and personal information concerning 92106.
revision of Vaccine Information individuals associated with the grant Contact Person: Ranga Srinivas, Ph.D.,
Statements; and, recommending to the Chief, Extramural Project Review Branch,
applications, the disclosure of which National Institute on Alcohol Abuse and
Director of the National Vaccine would constitute a clearly unwarranted
Program research related to vaccine Alcoholism, National Institutes of Health,
invasion of personal privacy. 5365 Fishers Lane, Room 2085, Rockville,
injuries which should be conducted to
daltland on DSKBBV9HB2PROD with NOTICES
Name of Committee: National Institute on MD 20852, (301) 451–2067, srinivar@
carry out the VICP. mail.nih.gov.
The agenda items for the March 8, Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict (Catalogue of Federal Domestic Assistance
2018, meeting will include, but are not Applications. Program Nos. 93.271, Alcohol Research
limited to, updates from DICP, Date: March 27, 2018. Career Development Awards for Scientists
Department of Justice (DOJ), National Time: 11:00 a.m. to 2:00 p.m. and Clinicians; 93.272, Alcohol National
Vaccine Program Office (NVPO), Agenda: To review and evaluate grant Research Service Awards for Research
Immunization Safety Office (Centers for applications. Training; 93.273, Alcohol Research Programs;
VerDate Sep<11>2014 17:58 Feb 23, 2018 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\26FEN1.SGM 26FEN1](https://thefederalregister.org/doc/83_FR_8326/page/2.svg)
Document Created: 2018-02-24 01:00:22
Document Modified: 2018-02-24 01:00:22
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Dates | The meeting will be held on March 8, 2018, at 10:00 a.m. ET. | |
| Contact | Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, Division of Injury Compensation Programs (DICP), HRSA in one of three | |
| FR Citation | 83 FR 8288 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR